X

Rubriques :

Maroc - NEWS.MEDICAL.NET - A la Une - 03/Mar 05:06

Medtronic receives FDA approval for BrainSense Adaptive DBS technology

For the one million people diagnosed with Parkinson's disease in the United States, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug Administration (FDA) approval of BrainSense™ Adaptive deep brain stimulation (aDBS) and BrainSense™ Electrode Identifier (EI).

Articles similaires

Indivior Announces FDA Approval of Label Changes for Sublocade (buprenorphine extended-release) Injection

drugs.com - 24/Feb 23:02

Richmond, VA, February 24, 2025 – Indivior PLC (Nasdaq/LSE: INDV), a global leader in addiction treatment, today announced that the U.S. Food...

MedRhythms Announces FDA Class II Listing for Movive™ to Support Gait Rehabilitation and Motor Function for Parkinson's Disease

healthtechzone.com - 06/Mar 14:30

Spark Biomedical Receives Health Canada’s Medical Device License for Sparrow Ascent Opioid Withdrawal Treatment

financialpost.com - 05/Mar 14:53

New Health Canada Approval Allows Spark Biomedical to Offer Drug-Free Opioid Withdrawal Relief Across Canada. Dallas, TX, March 05, 2025 (GLOBE...

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the Furoscix Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease

drugs.com - 07/Mar 00:03

BURLINGTON, Mass., March 06, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company...

GenAssist's IND application for GEN6050X receives US FDA clearance, a globally first─in─class base editing drug for duchenne muscular dystrophy

pharmabiz.com - 07/Mar 18:32

GenAssist Ltd (GenAssist), a pioneering gene─editing biotechnology company specializing in genome medicines, announced that it has received...

US FDA accepts for review GSK's BLA for depemokimab for asthma with type 2 inflammation and for chronic rhinosinusitis with nasal polyps

pharmabiz.com - 04/Mar 04:26

GSK plc announced the US Food and Drug Administration (FDA) has accepted for review the Biologics License Application for the use of depemokimab in...

40Hz brain stimulation may treat Alzheimer’s disease

knowridge.com - 07/Mar 00:47

For the past decade, scientists have been exploring a unique way to treat Alzheimer’s disease using gentle sensory stimulation at 40Hz, a brainwave...

BlueRock Therapeutics Receives FDA Fast Track Designation for OpCT-001 for the Treatment of Primary Photoreceptor Diseases

drugs.com - 27/Feb 02:03

Berlin, Germany, and Cambridge, MA, USA February 27, 2025 – Bayer AG and BlueRock Therapeutics LP, a clinical-stage cell therapy company and...

FDA Approves Miudella (copper intrauterine system) for the Prevention of Pregnancy

drugs.com - 24/Feb 22:02

ROSWELL, GA, February 24, 2025 – Sebela Women’s Health Inc., a part of Sebela Pharmaceuticals, today announced that the U.S. Food and Drug...

Brain stimulation could treat anxiety in people with Parkinson’s, scientists say

theguardian.com - 24/Feb 13:49

Researchers aim to develop new techniques to relieve symptoms after finding ‘strong’ link to brain wave

Les derniers communiqués

Aucun élément